Aortic Pressure Components — Clinical Insights

Aortic pressure emerges from the interaction between ventricular ejection and the arterial tree. Its principal descriptors—systolic blood pressure (SBP), diastolic blood pressure (DBP), and mean arterial pressure (MAP)—map to distinct clinical concerns: peak wall stress and suture-line protection (SBP), coronary driving pressure (DBP), and time-weighted organ perfusion (MAP). Contemporary guidance emphasizes mechanism-directed blood-pressure management and individualized targets, especially during cardiopulmonary bypass (CPB) where autoregulation boundaries vary among patients [1–4].

1) Systolic blood pressure (SBP)

Definition. The peak aortic pressure during LV systole.

Determinants. LV stroke volume/contractility, proximal aortic compliance/impedance, and timing/magnitude of wave reflections.

Clinical meaning.

• Contractile performance & stroke volume. With a stable DBP, a rising SBP often reflects increased stroke volume/contractility; falling SBP can signal impaired LV performance or hypovolemia.
• Mechanical stress on repairs. SBP governs instantaneous wall stress on the aortic root/arch and on suture lines after arch or valve repair. Post-repair hemostasis benefits from tempered SBP via afterload reduction, analgesia, and sedation while maintaining sufficient MAP for organ perfusion [1].
• Valve considerations. Elevated SBP increases transvalvular forces on repaired aortic/AV valves; early gentle targets protect leaflet coaptation and patch interfaces.

2) Diastolic blood pressure (DBP)

Definition. The nadir aortic pressure in diastole with the aortic valve closed.

Determinants. SVR, arterial elastance and recoil, heart rate (diastolic time), and diastolic runoff.

Clinical meaning.

• Coronary perfusion. LV coronary flow occurs predominantly in diastole; the driver is DBP minus LVEDP. Low DBP jeopardizes subendocardial perfusion and may precipitate ischemia and low output [2–4].
• Runoff physiology. Severe aortic regurgitation, systemic-to-pulmonary shunts (e.g., a modified BT shunt), or extensive AVMs siphon diastolic flow and depress DBP; recognize this pattern so it is not mislabeled as simple “vasodilation.”
• Heart-rate interplay. Tachycardia shortens diastole and increases dependence on DBP; bradycardia lengthens diastole and can amplify runoff effects in shunt physiology.

3) Mean arterial pressure (MAP)

Definition. Time-weighted integral of aortic pressure over the cardiac cycle—the most practical single index of systemic organ perfusion.

Bedside estimation. At typical heart rates: MAP ≈ DBP + ⅓(SBP − DBP); with tachycardia or reduced compliance, this under-weights systole and invasive waveforms better reflect the true integral.

Clinical meaning.

• Perfusion proxy. MAP trends align with global perfusion indicators (mental status, urine output, lactate, NIRS); interpret in context with venous saturation and examination [2–4].
• How MAP is achieved matters. Raising MAP via SVR (DBP↑) differs physiologically from increasing stroke volume (SBP and pulse pressure↑); the myocardial oxygen balance and afterload cost are not equivalent [3,4].

Evidence-informed target ranges

Guidelines and perioperative consensus statements typically suggest CPB MAP ranges of ~50–80 mmHg, with emphasis on staying within patient-specific autoregulation limits rather than chasing a single number [1,4]. Observational and physiologic data link time spent below the lower limit of cerebral autoregulation to neurologic and renal injury, motivating autoregulation-guided MAP titration during CPB [5,6]. Across randomized trials and meta-analysis, high vs. low CPB MAP strategies have not shown consistent differences in delirium, cognitive decline, stroke, AKI, or mortality; higher targets may increase transfusion requirements, underscoring the need to individualize rather than universally escalate pressures [2,10]. Surveys reflect broad variability in practice—most teams aim around MAP 60–90 mmHg (SBP ~90–140 mmHg) outside CPB and narrower targets during CPB, while acknowledging the weak evidence base [3,7].

4) Systems view: “The LV fills capillaries — the RV fills the LV”

In biventricular physiology, Qs must traverse systemic capillaries to return through the lungs and refill the LV. Adequate MAP sustains capillary perfusion; adequate DBP sustains the LV myocardium itself. When pulmonary or systemic resistances are unbalanced (e.g., lung disease or major shunts), Qs/Qp disequilibrium perturbs pressure–flow coupling and destabilizes both ventricles; management should re-align resistances and restore diastolic driving pressure [1,4].

5) Surgical and CHD implications

• Arch and proximal aorta repairs. Early post-repair care should limit SBP excursions to reduce anastomotic stress and bleeding while preserving end-organ perfusion—i.e., moderate SBP with MAP maintained inside autoregulation boundaries where possible [1,5].
• Valve repairs (aortic/AV). Avoid abrupt SBP surges; tune preload/afterload to preserve leaflet geometry and patch-tissue interfaces.
• Shunt physiology (e.g., Norwood + BT shunt). Diastolic runoff lowers DBP and can jeopardize coronary perfusion even when MAP looks “acceptable.” Strategies include tempering excess pulmonary flow, ventilatory adjustments to modulate PVR, and vasoactive selection that augments DBP rather than pure vasodilation [1,4].
• Coronary-dependent states. In LV hypertrophy, coronary anomalies, or low coronary reserve, prioritize DBP and diastolic time (rate control; avoid over-vasodilation) to protect subendocardium [3,4].

6) Practical bedside synthesis

1. Read the waveform. Narrow pulse pressure → low stroke volume/high SVR; wide pulse pressure → high stroke volume or reduced aortic compliance (or significant AR).
2. Target the mechanism.
• Low MAP with low DBP → vasodilation or diastolic runoff: consider vasoconstrictors and reduce runoff where feasible [4,8].
• Low MAP with narrow pulse pressure → hypovolemia or poor LV ejection: optimize preload/contractility.
3. Individualize during CPB. Favor autoregulation-guided MAP titration when monitoring is available (e.g., TCD or oximetry-derived indices), aiming to stay above the patient’s lower limit and avoiding unnecessary hypertension that adds afterload and transfusion risk [1,5,6,10].
4. Protect the repairs. Early after surgery: adequate MAP for organ perfusion, tempered SBP for suture lines, preserved DBP for coronaries.

References

[1] Wahba A, Kunst G, De Somer F, et al. 2024 EACTS/EACTAIC/EBCP guidelines on cardiopulmonary bypass in adult cardiac surgery. Eur J Cardiothorac Surg. 2025;67(2):ezae354.

[2] McEwen CC, Wijeysundera DN, Djaiani G, et al. High versus low blood pressure targets for cardiac surgery with cardiopulmonary bypass: a systematic review and meta-analysis of randomized controlled trials. Can J Anaesth. 2022;69(12):1390-1409.

[3] Pulido JN. Commentary: Target hemodynamic goals after cardiac surgery—time for a paradigm shift? J Thorac Cardiovasc Surg. 2019;158(5):1382-1383.

[4] Meng L, Alexander BS, Alexander LM, et al. Blood Pressure Targets in Perioperative Care. Hypertension. 2018;72(4):806-817.

[5] Ono M, Brady K, Easley RB, et al. Duration and magnitude of blood pressure below cerebral autoregulation is associated with major morbidity and mortality after cardiac surgery. Br J Anaesth. 2013;111(4):796-803.

[6] Hogue CW Jr, Brown CH, Cooter M, et al. Personalized blood pressure management during cardiopulmonary bypass to reduce neurologic complications: a randomized clinical trial. J Cardiothorac Vasc Anesth. 2021;35(12):3490-3499.

[7] Zhao K, Borrell S, Garg A, et al. Blood pressure management during cardiac surgery: a survey of Canadian cardiac anesthesiologists, perfusionists, and cardiac surgeons. Can J Anaesth. 2025;72(6):895-903.

[8] Ackland GL, Brudney CS, Cecconi M, et al. Hypotension as a marker or mediator of perioperative organ injury: a narrative review. Br J Anaesth. 2022;128(6):915-930.

[9] Francica A, Mazzola S, Ranucci M, et al. Mean Arterial Pressure (MAP) Trial: study protocol for a randomized controlled trial in adult cardiac surgery. Trials. 2024;25(1):441.

[10] Kotani Y, Takagi H, Ando T. High versus low blood pressure targets for cardiac surgery: an updated systematic review and meta-analysis. J Cardiothorac Vasc Anesth. 2022;36(12):4755-4764.